Fennell George reported option exercise involving 483 derivative units of IDEXX LABORATORIES INC DE at $0.00 for $0 on Nov 10, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Executive Vice President
Executive Vice President
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
483Incentive Stock Option (right-to-buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 10, 2026Option exercise
Filed
Nov 12, 2026, 5:00 PM ET2-day reporting delay
Accession
0000874716-26-000147Code M · Transaction 399325
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Option exercise706$0.00$0Trade 399323
Nov 10, 2026Option exercise560$0.00$0Trade 399324
Nov 10, 2026Option exercise706$141.60$99,969.60Trade 399320
Nov 10, 2026Option exercise560$178.26$99,825.60Trade 399321
Nov 10, 2026Option exercise483$206.94$99,952.02Trade 399322
6 transaction rows in this filing. Joint filers share the same rows.

IDXX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IDXX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −26%1w ago −19%1d ago +1.2%
Returns since7d30d90d180d1y

Footnotes in full

F1: Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022. F2: Grant of option to buy 560 shares of Issuer common stock that vested in one installment on February 14, 2023. F3: Grant of option to buy 483 shares of Issuer common stock that vests in one installment on February 14, 2024.